Roger Ferreira - Beleave CoFounder Officer
Insider
Roger Ferreira is CoFounder Officer of Beleave
Age | 37 |
Phone | 844-235-3283 |
Web | https://beleave.com |
Beleave Management Efficiency
The company has return on total asset (ROA) of (0.2501) % which means that it has lost $0.2501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.275) %, meaning that it generated substantial loss on money invested by shareholders. Beleave's management efficiency ratios could be used to measure how well Beleave manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 13 records | INSIDER Age | ||
Baochang Liu | Universe Pharmaceuticals | 44 | |
Thomas Flow | Akanda Corp | 46 | |
Sam Hsing | China Pharma Holdings | N/A | |
BComm BCom | Akanda Corp | 68 | |
Victoria Covel | Sonoma Pharmaceuticals | N/A | |
Lin Yang | Universe Pharmaceuticals | 48 | |
Kevin Pitts | Grey Cloak Tech | 63 | |
Robert Madden | Grey Cloak Tech | 51 | |
Tejinder Virk | Akanda Corp | 42 | |
BCom BAcc | Akanda Corp | 44 | |
Scott Landers | Grey Cloak Tech | N/A | |
Chad White | Sonoma Pharmaceuticals | 51 | |
Gang Lai | Universe Pharmaceuticals | 56 |
Management Performance
Return On Equity | -1.27 | |||
Return On Asset | -0.25 |
Beleave Leadership Team
Elected by the shareholders, the Beleave's board of directors comprises two types of representatives: Beleave inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Beleave. The board's role is to monitor Beleave's management team and ensure that shareholders' interests are well served. Beleave's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Beleave's outside directors are responsible for providing unbiased perspectives on the board's policies.
Vasilios Panagiotakopoulos, COO, CEO | ||
Myles Fontaine, VP Sales | ||
Justin Kosalka, Director Operations | ||
Keith CPA, Interim Officer | ||
Roger Ferreira, CoFounder Officer | ||
Lieutenant Gidlow, Head Outreach |
Beleave Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Beleave a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.27 | |||
Return On Asset | -0.25 | |||
Operating Margin | (3.87) % | |||
Current Valuation | 5.66 K | |||
Shares Outstanding | 566.37 M | |||
Price To Earning | (4.44) X | |||
Price To Book | 0 X | |||
Price To Sales | 0.0002 X | |||
Revenue | 2.37 M | |||
Gross Profit | 816.46 K |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |